Skip to main content
. 2019 Apr 8;8(4):477. doi: 10.3390/jcm8040477

Table 4.

Intraoperative neuromonitoring, visualisation and autotransplantation of parathyroids.

Procedure Total (n = 12,888) Multinodular Goitre (n = 9069) Graves’ Disease (n = 925) Other Entities (n = 2894)
Neuromonitoring RLN
 no 202 (1.6%) 133 (1.5%) 13 (1.4%) 56 (1.9%)
 yes 12,686 (98.4%) 8936 (98.5%) 912 (98.6%) 2837 (98.1%)
  intermittent IONM 10,488 (82.6%) 7430 (83.1%) 705 (77.3%) 2352 (82.9%)
  continuous IONM 2198 (17.4%) 1506 (16.9%) 207 (22.7%) 485 (17.1%)
Neuromonitoring SLN
 yes 997 (7.7%) 623 (6.9%) 67 (7.2%) 307 (10.6%)
 no 11,891 (92.3%) 8446 (93.1%) 858 (92.8%) 2587 (89.4%)
Identification PG
 no 324 (2.5%) 226 (2.5%) 6 (0.6%) 92 (3.2%)
 yes 12,564 (97.5) 8843 (97.5%) 919 (99.4%) 2802 (97.8%)
  1 PG 1043 (8.1%) 679 (7.5%) 12 (1.3%) 352 (12.2%)
  2 or more PG 11,521 (89.3%) 8164 (90%) 907 (98.1%) 2450 (84.7%)
Autotransplantation PG
 yes 1875 (15.3%) 1326 (14.6%) 206 (22.3%) * 343 (11.9%)
 no 11,013 (84.7%) 7743 (85.4%) 719 (77.7%) 2551 (88.1%)

RLN—recurrent laryngeal nerve; SLN-external branch superior laryngeal nerve; PG—parathyroid gland; IONM—intraoperative neuromonitoring; * p < 0.05 Graves’ disease vs. multinodular goitre and other entities combined.